The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

How does transplantation fit into the #Myelofibrosis treatment landscape?

We spoke to @mpdrc of @UTHealthSAMDA about the use of SCT in MF: http://ow.ly/DLhG50DHyFW

#TCTM21 @ASTCT #HemOnc #MPNsm #BMTsm

@EmmanuelKatsani @VJHemOnc @UAZCancer @ASTCT @SylvesterCancer @drkomanduri @amjimenezmd Happy to be part of an amazing transplant team at the @UAZCancer

Are you ready for #EBMT21?

We’ll talk to leading experts about cutting-edge research in #Transplantation and #CellularTherapy 👨‍⚕‍👩‍⚕‍

Join us at 👉http://ow.ly/rspV50DApND👈

More info: https://bit.ly/2ZJbehx

@VJHemOnc @TheEBMT #BMTsm #GvHD #CART #LEUsm #LYMsm #HemOnc

VLS-101, an antibody-drug conjugate targeting ROR1, shows efficacy in #MantleCellLymphoma and #DLBCL.

Find out more w/ Jacqueline Barrientos of @NorthwellHealth: http://ow.ly/DfmG50DHyAD

#ASH20 @ASH_hematology #HemOnc #Lymphoma #Lymsm #CTSM #TrialUpdate #ImmunoOnc #CaxTx

Load More...

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

How does transplantation fit into the #Myelofibrosis treatment landscape?

We spoke to @mpdrc of @UTHealthSAMDA about the use of SCT in MF: http://ow.ly/DLhG50DHyFW

#TCTM21 @ASTCT #HemOnc #MPNsm #BMTsm

@EmmanuelKatsani @VJHemOnc @UAZCancer @ASTCT @SylvesterCancer @drkomanduri @amjimenezmd Happy to be part of an amazing transplant team at the @UAZCancer

Are you ready for #EBMT21?

We’ll talk to leading experts about cutting-edge research in #Transplantation and #CellularTherapy 👨‍⚕‍👩‍⚕‍

Join us at 👉http://ow.ly/rspV50DApND👈

More info: https://bit.ly/2ZJbehx

@VJHemOnc @TheEBMT #BMTsm #GvHD #CART #LEUsm #LYMsm #HemOnc

VLS-101, an antibody-drug conjugate targeting ROR1, shows efficacy in #MantleCellLymphoma and #DLBCL.

Find out more w/ Jacqueline Barrientos of @NorthwellHealth: http://ow.ly/DfmG50DHyAD

#ASH20 @ASH_hematology #HemOnc #Lymphoma #Lymsm #CTSM #TrialUpdate #ImmunoOnc #CaxTx

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter